Cancer, cognitive impairment, and meditation

By Biegler Kelly   Alejandro Chaoul M.   Cohen Lorenzo  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 18-26

Informa Healthcare

Access to resources Recommend Favorite

Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide

By Andersen Kenneth Geving   Jensen Maj-Britt   Kehlet Henrik   Gärtner Rune   Eckhoff Lise   Kroman Niels  

Acta Oncologica, Vol. 51, Iss. 8, 2012-11 ,pp. : 1036-1044

Informa Healthcare

Access to resources Recommend Favorite

Intra-arterial Chemotherapy Followed by Chemo-embolisation in Unresectable Hepatocellular Carcinoma

By Colleoni M.   Liessi G.   Mastrapasqua G.   Nelli P.   Vicario G.   Sgarbossa G.   Pancheri F.   Manente P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 56-60

Elsevier

Access to resources Recommend Favorite

Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer

By Schmoor C.   Schumacher M.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 1, 1999-03 ,pp. : 31-38

Springer Publishing Company

Access to resources Recommend Favorite

The fog hasn’t lifted on “chemobrain” yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition

By Vardy Janette  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 35-37

Springer Publishing Company

Access to resources Recommend Favorite